Methods for diagnosing atherosclerosis by measuring endogenous heparin and methods for treating atherosclerosis using heparin

作者: John C. Klock

DOI:

关键词:

摘要: The present invention provides methods for measuring endogenous heparin in a mammal at levels that were previously undetectable. further features assessing the risk and progression of atherosclerosis treating or inhibiting atherosclerosis. also monitoring plasma subjects undergoing treatment. Additionally, kits assaying biological samples.

参考文章(54)
CA de Swart, B Nijmeyer, JM Roelofs, JJ Sixma, Kinetics of intravenously administered heparin in normal humans Blood. ,vol. 60, pp. 1251- 1258 ,(1982) , 10.1182/BLOOD.V60.6.1251.BLOODJOURNAL6061251
Thomas J. McAvoy, The biologic half-life of heparin. Clinical Pharmacology & Therapeutics. ,vol. 25, pp. 372- 379 ,(1979) , 10.1002/CPT1979253372
John C. Klock, Christopher M. Starr, The Different Faces of Disease Advances in Experimental Medicine and Biology. ,vol. 376, pp. 13- 25 ,(1995) , 10.1007/978-1-4615-1885-3_2
R Ceustermans, M Hoylaerts, M De Mol, D Collen, Preparation, characterization, and turnover properties of heparin-antithrombin III complexes stabilized by covalent bonds. Journal of Biological Chemistry. ,vol. 257, pp. 3401- 3408 ,(1982) , 10.1016/S0021-9258(18)34791-4
William Jonathan Cummins, Richard West, Mark Samuel Jonathan Briggs, Peter Jackson, John Anthony Smith, Analysis of carbohydrates ,(1997)